Cannabinoid Therapy Market Players Contribute Majorly towards Innovative Trends, details Fact.MR report
A cannabinoid is a class of chemical compounds that change the neurotransmitter release in the brain by acting on cannabinoid receptors in the cells. Cannabinoids are derived from plants and are also referred to as the phytocannabinoids. Majority of the cannabinoids available for cannabinoid therapy are cannabis-driven, but there are several different plants from which cannabinoids can be derived as well. Approximately 70 plant compounds are identified for cannabinoids. Majority of these cannabinoids exhibit pharmacological activity and also at times, psychoactive effects. According to the study by Mechoulam and Hanus (2000), delta-9-tetrahydrocannabinol is the most intensively researched cannabinoid and exhibits the greatest psychoactivity among all the available cannabinoids. Cannabinoid therapy includes the use of these chemical compounds for various cancer cases, neuropathic disorders, spasticity conditions and is used for sedation as well.
Request Free Sample Report-
https://www.factmr.com/connectus/sample?flag=S&rep_id=2833
Cannabinoid Therapy Market: Segmentation
Tentatively, the global cannabinoid therapy market can be segmented on the basis of Cephalometric X-ray type, technology, product type, end users, and geography.
Based on therapy type, the global cannabinoid therapy market is segmented as:
Tetrahydrocannabinol (THC)
Cannabidiol (CBD)
Cannabinol (CBN)
Others
Based on product type, the global cannabinoid therapy market is segmented as:
Oils
Capsules
Isolates
E-liquids
Topicals
Others
Based on end users, the global cannabinoid therapy market is segmented as:
Hospitals
Cancer Centers
Military Healthcare Settings
Rehabilitation Centers
Others
Have Any Query? Ask our Industry Experts
-
https://www.factmr.com/connectus/sample?flag=AE&rep_id=2833
Cannabinoid Therapy Market: Key Players
The major market participants operating in the global cannabinoid therapy market are Zynerba Pharmaceuticals, Cannabics Pharmaceuticals Inc., GW Pharmaceuticals PLC., Enecta, Alpha-CAT, Teewinot Life Sciences, Tilray, GD Pharma, Cyrelian Pty Ltd., Cape Bouvard Technologies Pty Ltd, MedReleaf Australia, and AusCann Group Holdings Pty Ltd.
Pertinent aspects this study on the Cannabinoid Therapy market tries to answer exhaustively are:
• What is the forecast size (revenue/volumes) of the most lucrative regional market?
• What is the share of the dominant product/technology segment in the Cannabinoid Therapy market?
• What regions are likely to witness sizable investments in research and development funding?
• What are Covid 19 implication on Cannabinoid Therapy market and learn how businesses can respond, manage and mitigate the risks?
• Which countries will be the next destination for industry leaders in order to tap new revenue streams?
• Which new regulations might cause disruption in industry sentiments in near future?
• Which is the share of the dominant end user?
• Which region is expected to rise at the most dominant growth rate?
• Which technologies will have massive impact of new avenues in the Cannabinoid Therapy market?
• Which key end-use industry trends are expected to shape the growth prospects of the Cannabinoid Therapy market?
• What factors will promote new entrants in the Cannabinoid Therapy market?
• What is the degree of fragmentation in the Cannabinoid Therapy market, and will it increase in coming years?
Why Choose Fact.MR?
Fact.MR follows a multi- disciplinary approach to extract information about various industries. Our analysts perform thorough primary and secondary research to gather data associated with the market. With modern industrial and digitalization tools, we provide avant-garde business ideas to our clients. We address clients living in across parts of the world with our 24/7 service availability.